Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ACHV

Achieve Life Sciences, Inc.

Healthcare · USD

Set alert

Price alert · ACHV

All alert types
6.83 USD -0.36 -5.01%
As of Oct 30, 2026 Extended hours 6.83 0.00%
Bid
6.83 × 2
Ask
6.84 × 2
6.57 Day range 7.27
2.65 52-week range 8.53
YTD
+37.42%
1 year
+30.34%
Open
7.12
Prev close
7.19
Mkt cap
704.19M
Vol
1.38M
Avg vol
1.45M
EPS
-1.69
P/E
0.00
Div yield
0.00%
More statistics
Low
6.57
High
7.27
Forward P/E
-3.30
Beta
1.58
Short ratio
23.98
Inst. own
59.60%
Dividend
0.00
Ex-div date
50-d avg
4.53
200-d avg
4.66
1y target
16.44

5D chart

Chart tools
Interval
1m5m15m30m
ACHV five-day price chart6.456.656.847.047.23Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-2.50 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.0×
FY 2016: -0.7×FY 2017: -0.6×FY 2018: -0.3×FY 2019: -0.3×FY 2020: -1.5×FY 2021: -1.9×FY 2022: -0.6×FY 2023: -2.7×FY 2024: -2.8×FY 2025: -4.0×
FY 2016 5y median -2.7× FY 2025
P/S 0.0×
FY 2016: 3.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 10.1×
FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.6×FY 2021: 2.3×FY 2022: 3.1×FY 2023: -56.4×FY 2024: 5.4×FY 2025: 10.1×
FY 2016 5y median 3.1× FY 2025
P/FCF -4.4×
FY 2016: -0.5×FY 2017: -0.7×FY 2018: -0.4×FY 2019: -0.3×FY 2020: -1.6×FY 2021: -2.1×FY 2022: -0.7×FY 2023: -3.3×FY 2024: -3.8×FY 2025: -4.4×
FY 2016 5y median -3.3× FY 2025
EV/EBITDA -3.9×
FY 2016: 0.0×FY 2017: -0.1×FY 2018: 0.4×FY 2019: 0.7×FY 2020: 0.9×FY 2021: -1.1×FY 2022: -0.4×FY 2023: -3.1×FY 2024: -2.9×FY 2025: -3.9×
FY 2016 5y median -2.9× FY 2025
EV/Sales 0.0×
FY 2016: -0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -22.8%
FY 2016: -198.5%FY 2017: -141.8%FY 2018: -251.2%FY 2019: -349.4%FY 2020: -61.3%FY 2021: -46.6%FY 2022: -144.8%FY 2023: -30.0%FY 2024: -26.4%FY 2025: -22.8%
FY 2016 5y median -30.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -418.6%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -397.6%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -254.0%
FY 2016: -106.1%FY 2017: -134.3%FY 2018: -80.3%FY 2019: -90.8%FY 2020: -39.3%FY 2021: -118.2%FY 2022: -510.1%FY 2023: 2059.0%FY 2024: -190.6%FY 2025: -254.0%
FY 2016 5y median -190.6% FY 2025
ROIC -150.5%
FY 2016: -100.9%FY 2017: -65.1%FY 2018: -81.0%FY 2019: -89.8%FY 2020: -39.4%FY 2021: -76.9%FY 2022: -166.5%FY 2023: -178.3%FY 2024: -122.1%FY 2025: -150.5%
FY 2016 5y median -150.5% FY 2025
ROA -130.8%
FY 2016: -73.3%FY 2017: -107.0%FY 2018: -66.5%FY 2019: -77.8%FY 2020: -36.4%FY 2021: -69.8%FY 2022: -141.3%FY 2023: -153.9%FY 2024: -103.1%FY 2025: -130.8%
FY 2016 5y median -130.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -72.1%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -40.5%
FY 2016: -13.0%FY 2017: 68.7%FY 2018: -93.2%FY 2019: -29.0%FY 2020: 10.8%FY 2021: -124.4%FY 2022: -23.3%FY 2023: 33.2%FY 2024: -43.4%FY 2025: -40.5%
FY 2016 FY 2025
EPS (diluted) -0.8%
FY 2016: -4.3%FY 2017: 70.1%FY 2018: 83.6%FY 2019: 45.8%FY 2020: 86.2%FY 2021: 24.9%FY 2022: 2.5%FY 2023: 62.0%FY 2024: 17.3%FY 2025: -0.8%
FY 2016 FY 2025
Free Cash Flow -66.2%
FY 2016: -213.9%FY 2017: 69.4%FY 2018: -17.2%FY 2019: -43.1%FY 2020: 11.6%FY 2021: -118.2%FY 2022: -27.6%FY 2023: 34.8%FY 2024: -21.5%FY 2025: -66.2%
FY 2016 FY 2025

Financial Health

Current Ratio 4.4×
FY 2016: 3.2×FY 2017: 2.9×FY 2018: 4.8×FY 2019: 6.0×FY 2020: 12.6×FY 2021: 9.8×FY 2022: 1.3×FY 2023: 0.8×FY 2024: 5.5×FY 2025: 4.4×
FY 2016 5y median 4.4× FY 2025
Quick Ratio 4.4×
FY 2016: 3.2×FY 2017: 2.8×FY 2018: 4.8×FY 2019: 6.0×FY 2020: 12.6×FY 2021: 9.8×FY 2022: 1.3×FY 2023: 0.8×FY 2024: 5.5×FY 2025: 4.4×
FY 2016 5y median 4.4× FY 2025
Debt / Equity 0.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.5×FY 2022: 2.0×FY 2023: -11.6×FY 2024: 0.5×FY 2025: 0.7×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 0.8×FY 2017: 0.4×FY 2018: 0.8×FY 2019: 1.0×FY 2020: 2.5×FY 2021: 0.9×FY 2022: 0.2×FY 2023: -0.0×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage -67.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -22.8×FY 2023: -9.6×FY 2024: -17.9×FY 2025: -67.0×
FY 2016 5y median -17.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31